Veradermics (NYSE:MANE – Get Free Report) had its price target upped by research analysts at Needham & Company LLC from $136.00 to $164.00 in a report released on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the stock. Needham & Company LLC’s price objective would indicate a potential upside of 28.62% from the stock’s current price.
Several other equities research analysts have also issued reports on the stock. Weiss Ratings assumed coverage on shares of Veradermics in a research note on Tuesday, May 26th. They set a “sell (d+)” rating on the stock. Citigroup upped their price target on Veradermics from $120.00 to $135.00 and gave the stock a “buy” rating in a report on Monday, May 18th. Wall Street Zen lowered Veradermics from a “hold” rating to a “sell” rating in a report on Sunday. Jefferies Financial Group boosted their price objective on Veradermics from $138.00 to $182.00 and gave the company a “buy” rating in a research report on Tuesday, July 7th. Finally, Lifesci Capital started coverage on Veradermics in a research note on Tuesday, June 16th. They set an “outperform” rating and a $135.00 target price for the company. Seven research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Veradermics presently has an average rating of “Moderate Buy” and a consensus price target of $149.43.
Read Our Latest Report on MANE
Veradermics Stock Performance
Veradermics (NYSE:MANE – Get Free Report) last posted its earnings results on Tuesday, May 12th. The company reported ($1.32) earnings per share for the quarter, missing the consensus estimate of ($0.56) by ($0.76).
Veradermics Company Profile
MANE is a global manufacturer and supplier of flavors, fragrances and ingredients for the food, beverage, personal care, household and fine fragrance markets. Headquartered in France, the company develops and produces aromatic solutions that are used by consumer goods companies, food processors, perfumers and formulators seeking sensory impact, taste modulation and olfactory character for their products.
The company’s product portfolio includes savory and sweet flavor systems, beverage concentrates, natural extracts, essential oils, fragrance compounds, cosmetic ingredients and specialty functional solutions such as taste enhancers and odor masking agents.
See Also
- Five stocks we like better than Veradermics
- Why ASML’s AI Monopoly Is Still Getting Stronger
- Apple’s AI Toll Booth Thesis Faces Its Biggest Test Yet Before Earnings
- 2 Quantum Stocks That Could Challenge IonQ’s Leadership
- Plot Twist: 12 States Could Stall the Paramount-Warner Bros. Discovery Mega-Merger
Receive News & Ratings for Veradermics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradermics and related companies with MarketBeat.com's FREE daily email newsletter.
